248 related articles for article (PubMed ID: 19741733)
21. Foamy-virus-mediated gene transfer to canine repopulating cells.
Kiem HP; Allen J; Trobridge G; Olson E; Keyser K; Peterson L; Russell DW
Blood; 2007 Jan; 109(1):65-70. PubMed ID: 16968897
[TBL] [Abstract][Full Text] [Related]
22. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
23. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
[TBL] [Abstract][Full Text] [Related]
24. Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense Env.
Braun SE; Lu XV; Wong FE; Connole M; Qiu G; Chen Z; Slepushkina T; Slepushkin V; Humeau LM; Dropulic B; Johnson RP
Hum Gene Ther; 2007 Jul; 18(7):653-64. PubMed ID: 17600461
[TBL] [Abstract][Full Text] [Related]
25. Lentiviral vectors for gene therapy of HIV-1 infection.
Mautino MR
Curr Gene Ther; 2002 Feb; 2(1):23-43. PubMed ID: 12108972
[TBL] [Abstract][Full Text] [Related]
26. Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication.
Bahner I; Sumiyoshi T; Kagoda M; Swartout R; Peterson D; Pepper K; Dorey F; Reiser J; Kohn DB
Mol Ther; 2007 Jan; 15(1):76-85. PubMed ID: 17164778
[TBL] [Abstract][Full Text] [Related]
27. Lentivirus-mediated expression of mutant MGMTP140K protects human CD34+ cells against the combined toxicity of O6-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomide.
Chinnasamy D; Fairbairn LJ; Neuenfeldt J; Treisman JS; Hanson JP; Margison GP; Chinnasamy N
Hum Gene Ther; 2004 Aug; 15(8):758-69. PubMed ID: 15319033
[TBL] [Abstract][Full Text] [Related]
28. Preparation of simian foamy virus type-1 vectors.
Park J; Mergia A
Cold Spring Harb Protoc; 2011 Sep; 2011(9):. PubMed ID: 21880822
[TBL] [Abstract][Full Text] [Related]
29. Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.
Morris KV; Rossi JJ
Curr HIV Res; 2004 Apr; 2(2):185-91. PubMed ID: 15078182
[TBL] [Abstract][Full Text] [Related]
30. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
Bai J; Banda N; Lee NS; Rossi J; Akkina R
Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
[TBL] [Abstract][Full Text] [Related]
31. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication.
Bonyhadi ML; Moss K; Voytovich A; Auten J; Kalfoglou C; Plavec I; Forestell S; Su L; Böhnlein E; Kaneshima H
J Virol; 1997 Jun; 71(6):4707-16. PubMed ID: 9151864
[TBL] [Abstract][Full Text] [Related]
32. Sustained high-level polyclonal hematopoietic marking and transgene expression 4 years after autologous transplantation of rhesus macaques with SIV lentiviral vector-transduced CD34+ cells.
Kim YJ; Kim YS; Larochelle A; Renaud G; Wolfsberg TG; Adler R; Donahue RE; Hematti P; Hong BK; Roayaei J; Akagi K; Riberdy JM; Nienhuis AW; Dunbar CE; Persons DA
Blood; 2009 May; 113(22):5434-43. PubMed ID: 19339698
[TBL] [Abstract][Full Text] [Related]
33. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.
Li MJ; Kim J; Li S; Zaia J; Yee JK; Anderson J; Akkina R; Rossi JJ
Mol Ther; 2005 Nov; 12(5):900-9. PubMed ID: 16115802
[TBL] [Abstract][Full Text] [Related]
34. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.
Leurs C; Jansen M; Pollok KE; Heinkelein M; Schmidt M; Wissler M; Lindemann D; Von Kalle C; Rethwilm A; Williams DA; Hanenberg H
Hum Gene Ther; 2003 Apr; 14(6):509-19. PubMed ID: 12718762
[TBL] [Abstract][Full Text] [Related]
35. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.
Mochizuki H; Schwartz JP; Tanaka K; Brady RO; Reiser J
J Virol; 1998 Nov; 72(11):8873-83. PubMed ID: 9765432
[TBL] [Abstract][Full Text] [Related]
36. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.
Anderson JS; Javien J; Nolta JA; Bauer G
Mol Ther; 2009 Dec; 17(12):2103-14. PubMed ID: 19690520
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
38. In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication.
Davis BM; Humeau L; Dropulic B
Mol Ther; 2004 Feb; 9(2):160-72. PubMed ID: 14759800
[TBL] [Abstract][Full Text] [Related]
39. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
[TBL] [Abstract][Full Text] [Related]
40. Evidence for the in vivo safety of insulated foamy viral vectors.
Browning DL; Everson EM; Leap DJ; Hocum JD; Wang H; Stamatoyannopoulos G; Trobridge GD
Gene Ther; 2017 Mar; 24(3):187-198. PubMed ID: 28024082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
